The 10 products range initially within a dosage group of tablets and capsules with other dosage forms to follow.
The buyer has placed an initial assorted order for 2 million capsules/tablets which incorporates selected antibiotics, anti-hypertensive, antacids, proton pump inhibitors and anti-histamine in the form of tablets and capsules.
SOHM Inc president and CEO Shailesh Shah said the Sri Lankan market is very accessible for India based manufacturing operations.
"This close proximity allows us to supply our pharmaceutical products at very affordable and competitive price points in the region. Sri Lanka is considered a gateway to Southeast Asia and one of the fastest growing pharmaceutical markets in the world. We are positioning SOHM to be a major distributor of generic pharmaceuticals in this region," Shah said.